Cargando…

Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy

BACKGROUND: Whether biochemical recurrence (BR) is a significant predictive factor of mortality after definitive radiation therapy for prostate cancer remains unknown. The aim of the current study was to investigate the relation between BR and overall mortality (OAM) in high‐risk prostate cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasuya, Goro, Ishikawa, Hitoshi, Tsuji, Hiroshi, Nomiya, Takuma, Makishima, Hirokazu, Kamada, Tadashi, Akakura, Koichiro, Suzuki, Hiroyoshi, Shimazaki, Jun, Haruyama, Yasuo, Kobashi, Gen, Tsujii, Hirohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094521/ https://www.ncbi.nlm.nih.gov/pubmed/27351298 http://dx.doi.org/10.1002/cncr.30050

Ejemplares similares

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2017)

Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2018)

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2019)

Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
por: Kasuya, Goro, et al.
Publicado: (2017)

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
por: Maruyama, Katsuya, et al.
Publicado: (2017)

Up-to-date results of carbon-ion radiotherapy for prostate cancer
por: Nomiya, Takuma, et al.
Publicado: (2014)

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks
por: Nomiya, T, et al.
Publicado: (2014)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
por: Yasuda, Shigeo, et al.
Publicado: (2019)

First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry
por: Bhattacharyya, Tapesh, et al.
Publicado: (2019)

Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023)

Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy
por: Hirata, Yoshito, et al.
Publicado: (2015)

A Review of Update Clinical Results of Carbon Ion Radiotherapy
por: Tsujii, Hirohiko, et al.
Publicado: (2012)

Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
por: Takahashi, Wataru, et al.
Publicado: (2014)

Evolution of Carbon Ion Radiotherapy at the National Institute of Radiological Sciences in Japan
por: Mohamad, Osama, et al.
Publicado: (2018)

Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013)

Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling
por: Hirata, Yoshito, et al.
Publicado: (2018)

Carbon ion radiotherapy for basal cell adenocarcinoma of the head and neck: preliminary report of six cases and review of the literature
por: Jingu, Keiichi, et al.
Publicado: (2010)

Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
por: Sato, Naohide, et al.
Publicado: (1993)

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer
por: Kang, Yu‐Mei, et al.
Publicado: (2022)

Association between hypertension and hearing impairment in health check-ups among Japanese workers: a cross-sectional study
por: Umesawa, Mitsumasa, et al.
Publicado: (2019)

Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer
por: Takakusagi, Yosuke, et al.
Publicado: (2020)

Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study
por: Makishima, Hirokazu, et al.
Publicado: (2018)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Relationships between dipstick proteinuria and risk of hearing impairment among Japanese workers: a prospective cohort study
por: Umesawa, Mitsumasa, et al.
Publicado: (2019)

Publisher Correction: A large-scale population-based epidemiological study on the prevalence of central sensitization syndromes in Japan
por: Haruyama, Yasuo, et al.
Publicado: (2021)

A large-scale population-based epidemiological study on the prevalence of central sensitization syndromes in Japan
por: Haruyama, Yasuo, et al.
Publicado: (2021)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs
por: Kato, Takamitsu A, et al.
Publicado: (2011)

Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS)
por: Kasuya, Goro, et al.
Publicado: (2019)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Association between the interval of worksite dental check-ups and dental and medical expenditures: a single-site, 12-year follow-up study in Japan
por: Ichihashi, Toru, et al.
Publicado: (2022)

Discussions on target theory: past and present
por: Nomiya, Takuma
Publicado: (2013)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
por: Bassey, Iya Eze, et al.
Publicado: (2020)

Association between dipstick proteinuria and hearing impairment in health check-ups among Japanese workers: a cross-sectional study
por: Umesawa, Mitsumasa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8ps6fkrtphbsfkhuqc8ff6dafh